Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, +30 authors Jesse S BoehmNature communications2016Identifying therapeutic targets in rare cancers remains challenging due to the paucity of established models to perform preclinical studies. As a proof-of-concept, we developed a patient-derived… (More)